Combined targeting of mTOR and c-MET signaling pathways for effective management of epithelioid sarcoma
Yoshinori Imura(Osaka University), Norifumi Naka(Osaka International Cancer Institute)
Cited by 47
Related Papers
Synovial Sarcoma Is a Stem Cell Malignancy
|Stem Cells|2010|202
Establishment of a novel clear cell sarcoma cell line (Hewga-CCS), and investigation of the antitumor effects of pazopanib on Hewga-CCS
|BMC Cancer|2014|34
Functional and therapeutic relevance of hepatocyte growth factor/c‐MET signaling in synovial sarcoma
|Cancer Science|2016|32